Back to results
RecruitingPhase 1Phase 2

Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast Cancer

NCT06167694

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Chinese PLA General Hospital Fifth Medical Center

Beijing, Beijing Municipality, China

+1 additional location

View on ClinicalTrials.gov
Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast Cancer — TrialFind